Dynavax Technologies
DVAX
$11.21
Share price
0.36%
Change (1 day)
6.26%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - P/B ratio
P/B ratio as of April 2024 : 2.36
According to Dynavax Technologies
's latest financial reports the company has a price-to-book ratio of 2.36.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Dynavax Technologies - P/B ratio (from 2004 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.90 | 24.33% |
| 2022-12-31 | 2.34 | -69.22% |
| 2021-12-31 | 7.59 | -9.15% |
| 2020-12-31 | 8.35 | -85.56% |
| 2019-12-31 | 57.9 | 534.5% |
| 2018-12-31 | 9.12 | 60.61% |
| 2017-12-31 | 5.68 | 232.84% |
| 2016-12-31 | 1.71 | -65.64% |
| 2015-12-31 | 4.97 | 12.48% |
| 2014-12-31 | 4.41 | 59.65% |
| 2013-12-31 | 2.76 | -39.06% |
| 2012-12-31 | 4.54 | 7.63% |
| 2011-12-31 | 4.22 | -40.63% |
| 2010-12-31 | 7.10 | -41.27% |
| 2009-12-31 | 12.1 | 483.38% |
| 2008-12-31 | 2.07 | -60.1% |
| 2007-12-31 | 5.19 | 12.62% |
| 2006-12-31 | 4.61 | 244.02% |
| 2005-12-31 | 1.34 | -57.63% |
| 2004-12-31 | 3.16 | |
| 2003-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.61 | -31.66% | 🇺🇸 USA |
 Amgen AMGN | 23.2 | 886.24% | 🇺🇸 USA |
 Biogen BIIB | 2.06 | -12.76% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.59 | 52.19% | 🇺🇸 USA |
 Merck MRK | 8.83 | 274.76% | 🇺🇸 USA |
 AstraZeneca AZN | 5.95 | 152.56% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 5.16 | 119.20% | 🇬🇧 UK |
 Agenus
AGEN | -1.67 | -170.94% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.92 | -18.30% | 🇮🇱 Israel |